Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.
about
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FutureA review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability.Cariprazine in schizophrenia: clinical efficacy, tolerability, and place in therapy.[Risk factors for treatment adherence in patients with schizophrenia: case-control study].A long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia.
P2860
Oral antipsychotic update: a brief review of new and investigational agents for the treatment of schizophrenia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Oral antipsychotic update: a b ...... he treatment of schizophrenia.
@en
type
label
Oral antipsychotic update: a b ...... he treatment of schizophrenia.
@en
prefLabel
Oral antipsychotic update: a b ...... he treatment of schizophrenia.
@en
P2860
P1433
P1476
Oral antipsychotic update: a b ...... he treatment of schizophrenia.
@en
P2860
P356
10.1017/S1092852912000727
P478
17 Suppl 1
P577
2012-11-01T00:00:00Z